Archean Chemical Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book

Q1 FY27 earnings call: what management guided on revenue, margins and order book.

Published 25 Aug 2026 | Chemicals & Petrochemicals | Market Cap: ₹6.1K Cr

Bromine volumes are expected to reach a run rate of 20,000 to 25,000 tons by the end of FY27 and aim for about 25,000 tons in FY28. Q1 FY27 showed strong sequential growth: standalone revenue +9%, EBITDA +26.3%, PAT +36%.

From Archean Chemical's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.

📊 Revenue & Sales Performance

Rank 3

→Bromine volumes are expected to reach a run rate of 20,000 to 25,000 tons by the end of FY27 and aim for about 25,000 tons in FY28.
→Industry growth for bromine is projected to be low to mid single digits annually.
→Expansion to 28,500 tons of bromine merchant sales could be achievable around FY28-FY29 with additional investments.
→Salt volumes are anticipated to normalize and grow with a double-digit increase expected from Q3 onwards as logistics issues resolve.
→Drilling and oilfield chemicals demand remains stable with ongoing development of new products, some in customer trials, expecting meaningful volumes in the second half of FY27.
→Semiconductor project capex and constructions start in late FY26, with full commercial operations expected 24-27 months after start, contributing to long-term growth.
→The derivatives business recently turned EBITDA positive and is expected to scale up earnings and volumes.

📈 Profitability & Margins

Rank 3

→Q1 FY27 showed strong sequential growth: standalone revenue +9%, EBITDA +26.3%, PAT +36%.
→Bromine volumes expected to reach 20,000-25,000 tons run rate by year-end and about 25,000 tons in FY28.
→Derivatives business (Acume) turned EBITDA positive and continues scaling with new product launches.
→Sulphate of Potash (SOP) trials progressing; phase 2 completion by Q3 FY27 expected to enable commercial scale-up.
→Semiconductor project (SiCSem) in execution phase; medium-term growth driver starting FY28 and beyond.
→Oilfield chemicals business scaling slowly; customer trials underway for mud chemicals and pack/starch products.
→Logistics improvements and cost optimizations expected to improve margins in H2 FY27.
→Capex of approx. USD 249 million for semiconductor project; 60-65% to be incurred in FY27, rest in FY28.
→Confident of delivering double-digit growth from Q3 FY27 in salt and bromine businesses.
→EPS growth driven by volume ramp-ups, derivative scale-up, and operational efficiencies over next 2-3 years.

See what Archean Chemical said on profitability & margins — free account, 30 seconds.

🏗️ Capital Expenditure Plans

Yes

→Semicon project capex: USD 249 million total
→ - 15%-20% already incurred
→ - 60%-65% to be spent in FY27 (this financial year), mainly for advances for plant, machinery, and equipment
→ - Remaining 40%-45% in FY28 (next financial year)
→Expansion plans for bromine production:
→ - Targeting 20,000-25,000 tons run rate by end of FY27
→ - 40,000 tons run rate expected by FY28-29 requiring further investment aligned with flame retardant project and capacity expansion
→New product development in drilling chemicals (pack, starch, bentonite, barite):
→ - Customer trials ongoing
→ - Expect meaningful volumes from H2 FY27 onwards for pack and starch and by end of FY27 for bentonite and barite
→Offgrid and advanced materials investments:
→ - Offgrid pilot plant started
→ - Investing in long-term opportunities with expected value accretion over 24-48 months
→Infrastructure and logistics:
→ - Expanded ports and fleet to improve efficiency; benefits expected from Q3 FY27 onwards

💰 Fundraising & Capital Structure

No information

→The transcript does not explicitly mention any current or planned new fundraising through debt or equity.
→Rajeev Kumar mentioned that the semiconductor project has a total capex of USD 249 million, with 15-20% already incurred, about 60-65% expected in the current financial year, and the balance in the next year. However, this is an ongoing project expenditure rather than new fundraising.
→The company is focused on stronger cash flow and disciplined capital allocation.
→No direct references were made to plans for raising additional debt or equity financing in the near term during this call.

See what Archean Chemical said on fundraising & capital structure — free account, 30 seconds.

📋 Order Book & Pipeline

No information

The provided pages from the Archean Chemical Industries Limited document do not explicitly mention current, expected orderbook, or pending orders details. However, from the discussion, a few relevant points can be inferred: - There have been order deferments affecting salt shipments due to conflicts in the Middle East (QVC orders postponed). - Logistics challenges have caused delays but there is no mention of lost orders. - Customer relationships remain strong, with no reported loss of orders despite commercial discipline exercised on some contracts. - Bromine and derivatives demand remains stable with ongoing customer trials and new account additions. - The company expects to liquidate existing inventory as normal through the rest of the year. For precise current or expected orderbook figures, further detailed financial disclosures or sections outside the provided text would be required.

Key Metrics

1 of 5 growth signals positive in the Q1 FY27 call.

Revenue

Rank 3

Margin

Rank 3

Capex

Yes

Fundraise

No information

Order Book

No information

How does Archean Chemical rank vs peers in Chemicals & Petrochemicals?

Pro feature

1Archean Chemical

Rev 3Mar 3

See full Chemicals & Petrochemicals sector rankings

Price

₹501

Market Cap

₹6.1K Cr

P/E Ratio

63.5

Archean Chemical — Quarterly revenue & net profit

Revenue Net Profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹301 Cr, net profit ₹12 Cr.

Full financials →

What Archean Chemical's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

Sudarshan Chem. (Q1 FY27)
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
Indo Borax & Ch. (Q1 FY27)
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
SRF (Q1 FY27)
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…
Deepak Fertilis. (Q1 FY27)
Long-term demand-supply balance looks stable with 6-7% market growth, supporting sustained revenues despite new capacity additions. Key concall takeaways from…

Compare:vs Solar Industries vs Pidilite Inds.vs SRF

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Archean Chemical Q1 FY27 results?

What is Archean Chemical share price analysis?

Archean Chemical currently shows a below-average growth signal. The stock trades at a P/E of 63.5 with a market cap of ₹6,146 Cr. Investors should review the full earnings analysis for detailed insights.

Is Archean Chemical planning capital expenditure?

Semicon project capex: USD 249 million total - 15%-20% already incurred - 60%-65% to be spent in FY27 (this financial year), mainly for advances for plant, machinery, and equipment - Remai

Keep Archean Chemical on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.

📊 Revenue & Sales Performance

🏗️ Capital Expenditure Plans

📋 Order Book & Pipeline

Key Metrics

Archean Chemical — Quarterly revenue & net profit

Continue your research

What Archean Chemical's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

Frequently Asked Questions